2023 Form 5500 filing — Day One Biopharmaceuticals 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241004190728NAL0021158192001) for Day One Biopharmaceuticals 401(K) Plan, reported by Day One Biopharmaceuticals, Inc. under EIN 83-2415215 and plan number 001. It reports 125 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241004190728NAL0021158192001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Day One Biopharmaceuticals, Inc.
- EIN
- 83-2415215
- Plan number
- 001
- Location
- Brisbane, CA
- Participants
- 125
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $10,485,353
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $10,485,353
- Employer contributions
- $1,327,021
- Participant contributions
- $2,568,736
- Total income / additions
- $6,624,802
- Benefits paid
- $198,067
- Administrative expenses
- -$223
- Total expenses
- $205,899
- Net increase / (decrease)
- $6,418,903
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Fidelity Investments Institutional | RECORDKEEPER | -$426 | $0 |